Report - IDT Investor Presentation 13Apr16 v3 FINAL...IDT currently the dominant supplier of active pharmaceutical ingredients for a significant oncology product, yet capturing only 2% of the

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form